Siersma Carolien L, Rottier Bart L, Hulscher Jan Bf, Bouman Katelijne, van Stuijvenberg Margriet
Department of Pediatrics, Beatrix Children's Hospital, CA51 Hanzeplein 1, PO Box 30001, 9700 RB, Groningen, The Netherlands.
BMC Res Notes. 2012 Dec 7;5:677. doi: 10.1186/1756-0500-5-677.
While an increased prevalence of cystic fibrosis (CF) in patients with jejunal atresia and ileal atresia (JIA) has been described previously, it still may not be a practice routine to indicate a sweat test or DNA test for CFTR mutations in newborns presenting with JIA. Leading textbooks do not mention JIA as a possible presenting clinical feature of CF. We describe two cases of JIA with a delayed diagnosis of CF (4 months [post mortem] and 19 months). This led to a retrospective review of all patients with JIA in our hospital. We hypothesised that also in the past although indicated further testing for CF had not always been performed.
Over an 18-year period from January 1991 until December 2008, all cases of JIA in our centre were reviewed (n=50). We compared patients who have been tested for CF (n=18) with patients who have not been tested for CF (n=32), with respect to their patient characteristics, either by logistic regression analysis or a nonparametric test (p<0.05).
Of all 50 patients the proportion of infants actually tested for CF was 18 (36%). A statistical significant difference between the group of patients who were tested for CF versus the group of those who were not tested was found in a higher occurrence of postoperative bilious retention after 7 days (56% versus 25%, respectively), and postoperative complications (78% versus 34%, respectively). CF was confirmed in 4 (8%).
Testing for CF in newborns presenting with JIA does not appear to be common practice. A timely diagnosis of CF leads to presymptomatic treatment and has beneficial effects on morbidity and mortality. CF should be tested for in all children with JIA. We recommend a sweat test for term children and CFTR DNA testing as a first step for preterm infants. Medical professional awareness may be increased if future editions of leading text books in the relevant fields should include JIA as an indication to follow an appropriate CF-diagnostic algorithm.
Statement on reporting of a clinical trial: This article is not based on a clinical trial.
虽然此前已有报道称空肠闭锁和回肠闭锁(JIA)患者中囊性纤维化(CF)的患病率有所增加,但对于患有JIA的新生儿,进行CFTR突变的汗液试验或DNA检测可能仍不是常规做法。主流教科书未提及JIA是CF可能出现的临床特征。我们描述了两例JIA患者,其CF诊断延迟(分别为4个月[尸检后]和19个月)。这促使我们对我院所有JIA患者进行回顾性研究。我们推测,过去虽然有必要进一步检测CF,但并非总是进行检测。
从1991年1月至2008年12月的18年间,对我院所有JIA病例(n = 50)进行回顾。我们通过逻辑回归分析或非参数检验(p < 0.05),比较了接受CF检测的患者(n = 18)和未接受CF检测的患者(n = 32)的患者特征。
在所有50例患者中,实际接受CF检测的婴儿比例为18例(36%)。在接受CF检测的患者组和未接受检测的患者组之间,发现术后7天胆汁潴留发生率较高(分别为56%和25%)以及术后并发症发生率较高(分别为78%和34%)存在统计学显著差异。4例(8%)确诊为CF。
对患有JIA的新生儿进行CF检测似乎并非常见做法。及时诊断CF可实现症状前治疗,并对发病率和死亡率产生有益影响。所有JIA患儿均应进行CF检测。对于足月儿,我们建议进行汗液试验;对于早产儿,CFTR DNA检测作为第一步。如果相关领域的主流教科书未来版本将JIA纳入遵循适当CF诊断算法的指征,可能会提高医学专业人员的认识。
关于临床试验报告声明:本文并非基于临床试验。